Matches in Wikidata for { <http://www.wikidata.org/entity/Q66401427> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66401427 description "clinical trial" @default.
- Q66401427 description "ensayu clínicu" @default.
- Q66401427 description "klinisch onderzoek" @default.
- Q66401427 description "клінічне випробування" @default.
- Q66401427 name "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma" @default.
- Q66401427 name "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma" @default.
- Q66401427 type Item @default.
- Q66401427 label "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma" @default.
- Q66401427 label "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma" @default.
- Q66401427 prefLabel "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma" @default.
- Q66401427 prefLabel "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma" @default.
- Q66401427 P1050 Q66401427-0F463C8C-D185-406E-8742-B8BAD60D04F7 @default.
- Q66401427 P1132 Q66401427-6ACD9F00-DDD8-4AD3-AEC7-46D59ADBAC88 @default.
- Q66401427 P1476 Q66401427-F11119E6-7143-4E63-BB70-F85D12E43166 @default.
- Q66401427 P17 Q66401427-03330614-7F1A-4129-9C7C-2956938375C4 @default.
- Q66401427 P17 Q66401427-682883C4-4C72-4D23-BE88-2A5FE15C13E2 @default.
- Q66401427 P17 Q66401427-7E506914-4B41-454B-A9D2-13A58B451173 @default.
- Q66401427 P17 Q66401427-80C14A4A-E1F3-4129-9DA1-29DFEE679245 @default.
- Q66401427 P17 Q66401427-A3C957EA-530A-4861-AAFF-3F8BDE3FD1C0 @default.
- Q66401427 P17 Q66401427-B6BFD969-3282-4023-A593-A888780F551B @default.
- Q66401427 P17 Q66401427-BBFC47B2-9B45-4214-A8CB-F6C706C59798 @default.
- Q66401427 P17 Q66401427-CA8B55FC-1217-40ED-9F51-35C6DBF3FF4C @default.
- Q66401427 P17 Q66401427-D6A4E288-6E65-4885-BB82-CE2349D772DC @default.
- Q66401427 P17 Q66401427-E7433B09-1725-4EC5-920E-6B87279DFE75 @default.
- Q66401427 P17 Q66401427-EB856D6C-26E7-4A90-B8FE-240C77A36BB8 @default.
- Q66401427 P17 Q66401427-FD7347E9-2AF0-4189-9159-04ED98D2F4E3 @default.
- Q66401427 P1813 Q66401427-A350164A-7FD6-46B5-AAC4-5A1EC9F1C8E6 @default.
- Q66401427 P2899 Q66401427-BA9F2512-88AF-473E-B518-6A5A861A80CA @default.
- Q66401427 P3098 Q66401427-F247EC5B-66A3-42C0-ADB9-9039C578A15A @default.
- Q66401427 P31 Q66401427-CD711FB3-9E29-4133-8389-C8D779087E6D @default.
- Q66401427 P4844 Q66401427-E2183F42-64FE-4208-B1A3-3304132B6F1C @default.
- Q66401427 P580 Q66401427-47701E75-815F-45A3-ACF3-6DBE2479ED03 @default.
- Q66401427 P582 Q66401427-C55F9983-799E-4309-A789-845ACAD952F2 @default.
- Q66401427 P6099 Q66401427-EF0227D5-970F-4F2C-A633-6CF0787CE1C8 @default.
- Q66401427 P8363 Q66401427-A53123A7-A227-4136-93D4-C6717AB59F75 @default.
- Q66401427 P1050 Q208414 @default.
- Q66401427 P1132 "+315" @default.
- Q66401427 P1476 "A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma" @default.
- Q66401427 P17 Q142 @default.
- Q66401427 P17 Q145 @default.
- Q66401427 P17 Q183 @default.
- Q66401427 P17 Q258 @default.
- Q66401427 P17 Q28 @default.
- Q66401427 P17 Q29 @default.
- Q66401427 P17 Q298 @default.
- Q66401427 P17 Q30 @default.
- Q66401427 P17 Q38 @default.
- Q66401427 P17 Q408 @default.
- Q66401427 P17 Q43 @default.
- Q66401427 P17 Q96 @default.
- Q66401427 P1813 "RAMO-2" @default.
- Q66401427 P2899 "+18" @default.
- Q66401427 P3098 "NCT02809053" @default.
- Q66401427 P31 Q30612 @default.
- Q66401427 P4844 Q412323 @default.
- Q66401427 P580 "2017-01-18T00:00:00Z" @default.
- Q66401427 P582 "2020-02-01T00:00:00Z" @default.
- Q66401427 P6099 Q42824827 @default.
- Q66401427 P8363 Q78089383 @default.